Zobrazeno 1 - 10
of 15
pro vyhledávání: '"V. O. Shender"'
Autor:
O. I. Aleshikova, N. A. Babaeva, E. V. Gerfanova, I. B. Antonova, V. O. Shender, A. E. Babaeva, L. A. Ashrafyan
Publikováno v:
Сеченовский вестник, Vol 14, Iss 2, Pp 21-30 (2023)
Ovarian cancer (OC) is a heterogenous disease in terms of genetic mutations and tumor phenotypes and can be divided into I and II types. Type II high grade tumors are more common, accompanied by ascites, and are the main cause of cancer-related death
Externí odkaz:
https://doaj.org/article/46809889bda842d3bfdcc1b144e82bf1
Autor:
I. M. Gruber, F. V. Donenko, E. A. Astashkina, V. O. Shender, R. K. Ziganshin, M. V. Kiselevsky
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 14, Iss 6, Pp 87-94 (2015)
In recent years, there is a persistent increase in the spread of community-acquired infections and medical care associated infections, the cause of which is S. aureus. Previously using liquid chromatography in combination with mass spectrometry (LC-M
Externí odkaz:
https://doaj.org/article/0e255bd14904493783082bfd4004cc14
Autor:
I. V. Alekseeva, A. A. Kuznetsova, O. A. Kladova, V. O. Shender, P. V. Schneider, O. S. Fedorova, N. A. Kuznetsov
Publikováno v:
Molecular Biology. 57:299-311
Autor:
I. A. Lutsenko, O. V. Loseva, A. V. Ivanov, I. K. Malyants, V. O. Shender, M. A. Kiskin, I. L. Eremenko
Publikováno v:
Russian Journal of Coordination Chemistry. 48:808-812
Autor:
N. A. Petinati, N. I. Drize, G. P. Arapidi, V. O. Shender, M. A. Lagar’kova, L. A. Kuz’mina, E. N. Parovichnikova, V. G. Savchenko
Publikováno v:
Bulletin of Experimental Biology and Medicine. 173:128-132
Autor:
I. A. Lutsenko, M. E. Nikiforova, K. A. Koshenskova, M. A. Kiskin, Yu. V. Nelyubina, P. V. Primakov, M. V. Fedin, O. B. Becker, V. O. Shender, I. K. Malyants, I. L. Eremenko
Publikováno v:
Russian Journal of Coordination Chemistry. 47:881-890
Publikováno v:
Russian Journal of Bioorganic Chemistry. 45:1-8
The spliceosome is necessary for the removal of intron sequences in transcribed pre-mRNA in eukaryotic cells. More than 200 proteins are involved in the process of pre-mRNA splicing; they coordinate the alternative splicing of most eukaryotic genes,
Autor:
Ksenia Anufrieva, Ilya A Semenov, Marat S. Pavlyukov, Olga Ivanova, Maria A. Lagarkova, Irina Malyants, V. O. Shender, Vadim M. Govorun, Polina V Shnaider
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 7872, p 7872 (2020)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
The malignant tumor is a complex heterogeneous set of cells functioning in a no less heterogeneous microenvironment. Like any dynamic system, cancerous tumors evolve and undergo changes in response to external influences, including therapy. Initially
Autor:
Sergey V. Razin, Bogdan Avanesyan, Omar L. Kantidze, Georgij Arapidi, Artem V. Luzhin, Polina V Shnaider, V. O. Shender, Nadezhda V. Petrova, Igor I. Kireev, Artem K. Velichko, Natalia Ovsyannikova
Publikováno v:
Cells, Vol 9, Iss 1423, p 1423 (2020)
Cells
Volume 9
Issue 6
Cells
Volume 9
Issue 6
Hyperthermia has been used as an adjuvant treatment for radio- and chemotherapy for decades. In addition to its effects on perfusion and oxygenation of cancer tissues, hyperthermia can enhance the efficacy of DNA-damaging treatments such as radiother
Autor:
Marat S. Pavlyukov, Polina V Shnaider, V. O. Shender, N. V. Antipova, Nikolay B. Pestov, Mihail I. Shakhparonov, Georgij Arapidi
Publikováno v:
Acta Naturae. 10:92-99
PON2 belongs to the paraoxonase protein family that consists of lactone hydrolyzing enzymes with different substrate specificities. Unlike other members of the family, PON2 exhibits substantial antioxidant activity, is localized predominantly inside